INFORMATION

We specialize in organizing high-quality business events, which provide only need-to-know information from leading industries’ experts.

CONTACT INFO

Email: registration@curtiswyss.com

Phone: +420 222 280 104

FOLLOW ME
Bacteriophage Therapy Conference
Curtis & Wyss Group is pleased to invite you to the Bacteriophage Therapy Conference, scheduled for September 13-14, 2021 in Barcelona, Spain. This premier B2B event will enable the participants to learn about the latest trends and developments in the bacteriophage therapies innovative field.

This agenda will aim addressing latest technological, scientific and commercialization trends in the industry. We are providing a multifunctional platform for the professionals to discuss the challenges and innovative ways to strengthen your business efficiency via the best R&D practices. It is an honor and privilege to invite you to participate in this Summit. We look forward to welcoming you at the Summit in Barcelona upcoming September.

HIGHLIGHTS

Overcoming the Challenges of Applying Bacteriophage Therapy in Battling Multidrug-Resistant Infections

Increasing the Accuracy of the Phage Treatment with the Clinical Trials Outcome Analysis

Novel Bacteriophage Strategies Tackling the Antibiotic Resistance

Good Manufacturing Practice Compliance for Bacteriophage Therapy Medicinal Products

Latest Practices of the Phage Resistance Constraining

Formulating Phage Therapies That Ensure Clinical Efficacy

AUDIENCE

Directors, VPs, Managers and Heads of:

Clinical Research

Drug Developers

R&D

Clinical Development

Product Development

Clinics & Hospitals

Academic Researches & Organizations

INDUSTRIES

Research Centers

Pharmaceutical

Biotechnology

Clinical Trials

Medical Bioinformatics

Academics & Clinicians

Service Providers

Keynote Speakers
Frenk Smrekar

CEO of JAFRAL

Christian Röhrig

Head of Research and Development, Micreos GmbH Switzerland

Dr. Jean-Paul Pirnay

Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital

Prof. Domenico Frezza

Cell and Molecular Biology, Università di Roma Tor Vergata

Dr. Grégory Resch

Head of the Laboratory of Bacteriophages and Phage Therapy, Lausanne University Hospital

Dr. Evgenii Rubalskii

Laboratory Leader National Phage Therapy Center, Hannover Medical School (MHH)

Dr. Mimi Yen

Chief Executive Officer & Co-Founder, PhagePro

Professor Marco Maria D’Andrea

Department of Biology, University of Rome - Tor Vergata

Media Partners